Skip to main content Skip to main menu
UF Health University of Florida
Division of Hematology & Oncology Department of Medicine in the College of Medicine
Brian H Ramnaraign

Brian H Ramnaraign, M.D.

Assistant Professor

Department: MD-UROLOGY
Business Phone: (352) 273-7832
Business Email: ramnaraign85@ufl.edu

On This Page

About Brian H Ramnaraign

Brian Ramnaraign, MD is an assistant professor of medicine in the division of hematology and oncology at the University of Florida College of Medicine.

Dr. Ramnaraign attended the University of Toronto for his undergraduate studies where he was awarded an Honors Bachelors of Science degree with a specialization in molecular genetics and microbiology. This was followed by attending St. George’s University for his medical training where he was awarded the degree of Doctor of Medicine and graduated cum laude.

His internal medicine residency was completed at SUNY Downstate in Brooklyn, NY where Dr. Ramnaraign had the opportunity to participate in rotations at Memorial Sloan Kettering in Manhattan. After residency he obtained a fellowship in geriatrics at the University of Pennsylvania in Philadelphia, PA.

Dr. Ramnaraign completed his hematology and oncology fellowship here at the University of Florida and upon completion stayed on as faculty. His wife is also here at the University of Florida and is training to be a pediatric oncologist.

His expertise and research interests are in the fields of genitourinary cancers, gastrointestinal cancers and neuroendocrine cancers. He is interested in the role of targeted therapies and immunotherapies in providing personalized treatments to individuals with advanced cancers.​

Accomplishments

  1. FLASCO Travel Award Winner

    UF, College of Medicine

  2. Runner Up – Research Day Award

    SUNY Downstate Department of Medicine

  3. Physician Recognition Award

    American Medical Association

  4. Dean’s List

    St. George’s University

Teaching Profile

Courses Taught

  1. PAS5010 – Intro to Medicine 1

    College of Medicine

Board Certifications

  • Geriatric Medicine
    American Board of Internal Medicine
  • Hematology
    American Board of Internal Medicine
  • Internal Medicine
    American Board of Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine

Clinical Profile

Specialties

  • Cancer
  • Hematology and Oncology

Areas of Interest

  • Bladder Cancer
  • Colorectal Cancer
  • Gastrointestinal Cancer
  • Kidney Cancer
  • Pancreatic Cancer
  • Prostate Cancer

Research Profile

Google Scholar: https://scholar.google.com/citations?user=OBsb4P4AAAAJ&hl=en

Open Researcher and Contributor ID (ORCID)

0000-0003-4051-4551

Areas of Interest

  • Cancer Immunotherapy
  • Esophageal cancer
  • Neuroendocrine Tumors
  • Pancreatic Cancer Biology
  • Prostate Cancer
  • Targeted Cancer Therapy

Publications

Academic Articles

Grants

  1. Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)

    Role:
    Principal Investigator
    Funding:
    NRG ONCOLOGY FOU via BAYER HEALTHCARE PHARMACEUTICALS

  2. MAIN-CAV: PHASE III RANDOMIZED TRIAL OF MAINTENANCE CABOZANTINIB AND AVELUMAB VS MAINTENANCE AVELUMAB AFTER FIRST-LINE PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH METASTATIC UROTHELIAL CANCER

    Role:
    Project Manager
    Funding:
    NRG ONCOLOGY FOU via NATL INST OF HLTH NCI

  3. Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)

    Active

    Role:
    Project Manager
    Funding:
    NRG ONCOLOGY FOU via NATL INST OF HLTH NCI

  4. Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors

    Active

    Role:
    Project Manager
    Funding:
    NRG ONCOLOGY FOU via NATL INST OF HLTH NCI

  5. Comparative Effectiveness Research for Neuroendocrine Tumors (CER-NET)

    Active

    Role:
    Project Manager
    Funding:
    UNIV OF IOWA via PATIENT-CENTERED OUTCOMES RES INST

  6. A Randomized Phase II Trial of Salvage Radiotherapy with Standard vs Enhanced Androgen Deprivation Therapy (with Enzalutamide) in Patients with Post-Prostatectomy PSA Recurrences with Aggressive Disease Features

    Role:
    Principal Investigator
    Funding:
    RADIATION THERAPY ONCOLOGY GROUP FOU

  7. A PHASE II STUDY OF DOSE-DENSE GEMCITABINE PLUS CISPLATIN (DDGC) IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER WITH BLADDER PRESERVATION FOR THOSE PATIENTS WHOSE TUMORS HARBOR DELETERIOUS DNA DAMAGE RESPONSE (DDR) GENE ALTERATIONS

    Active

    Role:
    Project Manager
    Funding:
    NRG ONCOLOGY FOU via NATL INST OF HLTH NCI

Education

  1. Fellowship, Hematology – Oncology

    University of Florida

  2. Fellowship, Geriatric Medicine

    University of Pennsylvania

  3. Internal Medicine

    State University of New York Health Science Center at Brooklyn

  4. Doctor of Medicine, Internal Medicine

    St. George’s University School of Medicine

  5. Honors Bachelors of Science, Molecular Genetics

    University of Toronto

Contact Details

Phones:
Business:
(352) 273-7832
Emails:
Business:
ramnaraign85@ufl.edu
Addresses:
Business Mailing:
PO Box 100278
 GAINESVILLE FL 32610
Business Street:
PO Box 100278
 GAINESVILLE FL 32610